Products mentioned by Ken Song
Products Ken Song has mentioned or recommended across podcast appearances.
SignalCast may earn a small commission on purchases through these links — at no extra cost to you. As an Amazon Associate we earn from qualifying purchases.
Remicade
“The T-cell engager class in autoimmunity parallels the anti-TNF wave of 25 years ago, when Humira, Enbrel, and Remicade each generated billions annually in a non-winner-take-all market.”
Humira
“The T-cell engager class in autoimmunity parallels the anti-TNF wave of 25 years ago, when Humira, Enbrel, and Remicade each generated billions annually in a non-winner-take-all market.”
Enbrel
“The T-cell engager class in autoimmunity parallels the anti-TNF wave of 25 years ago, when Humira, Enbrel, and Remicade each generated billions annually in a non-winner-take-all market.”
suzutamig
Authorby Candid Therapeutics
“Early clinical data from Candid's BCMA T-cell engager, suzutamig, shows that one treatment cycle — four weekly injections administered within 30 days — can produce durable immune reset in autoimmune patients.”